Navigation Links
Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers
Date:4/10/2008

iliate of Methodist Le Bonheur Healthcare ("MLH"), a Tennessee non-profit corporation established for the primary purpose of supporting and extending the health and welfare ministries of the Memphis, Arkansas and Mississippi Annual Conferences of The United Methodist Church. MLH is a health care delivery system which includes tertiary care, sub-acute care, hospice care, primary and specialty physician services and other health care services. MLH provides healthcare services to the residents of Memphis and portions of western Tennessee, eastern Arkansas and north Mississippi.

J.P. Morgan Securities Inc. is acting as Dealer Manager for the tender offer. This communication is for informational purposes only and does not constitute an offer or solicitation to purchase any of the Bonds or as an official confirmation of any transaction. The tender offer is made only pursuant to the tender offer documents which may be obtained from D.F. King & Co., Inc., which is serving as Information Agent, at (800) 949-2583.


'/>"/>
SOURCE Methodist Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston
2. SIEMENS, AlliedBarton, Methodist Hospital, and Family Planning Council Win Human Resources Department of the Year Awards
3. Methodist Health System Foundation Announces Largest Single Gift
4. Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement
5. Methodist Mansfield Celebrates First Year
6. Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care
7. New York Methodist Hospital to study airway bypass treatment for emphysema
8. Methodist Healthcare - Memphis Hospitals Announces the Commencement of the Tender Offer for Certain Designated Maturities of:
9. New Sleep Diagnostic Center Opens at Methodist Mansfield
10. Ben Barber Career Tech Academy Leaps Forward With Help From Methodist Mansfield
11. Methodist Healthcare - Memphis Hospitals Announces the Extension of Tender Offers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...Susan Butcher the famous iditarod champion was det...rticipate in the 300-mile sled dog race conducted ...of the 1100-mile Iditarod Trail Sled Dog Race. She...ce of survival with the same grit and confidence. ...
...There appears to be a remarkable laxity among the ...ng skin cancer. Felipe Beltran, the spokesman for ... has admitted that the organization’s drive agains...ed impact. The online study of the QIMR did not e...
...Researchers from Germany have discovered a novel, ...of coronary veins. This technique, called ECG-gate...DCT, is associated with very few complications // ... improved diagnostic quality and treatment. A com...
...A research was conducted by Selda Samakoglu and co...nter. This research opened new doors in the treatm.... The treatment combines both gene therapy and RNA...eatment has worked well in the laboratory stage an...
Other Medicine News:Health News:Treatment of Sickle Cell Anemia Using Gene Therapy. 2
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific...stCall/ -- Ironwood,Pharmaceuticals, Inc. (formerl...YSE: FRX ) today announced the presentation of re...s safety and efficacy in 420 patients with,irritab...sis of the data,indicates that once- daily oral do...
(Date:10/7/2008)...RKELEY, Calif., Oct. 7 /- Aerovance I... data from a Phase I trial of its Aerovant,inhalat... no evidence of,local irritancy following asthma p... 10 mg dose will be the highest of three doses inv...udy, which is scheduled to begin early,next year. ...
(Date:10/7/2008)...tient, Prospective Randomized Placebo-Controlled P...cant Improved Overall Survival., MOUNTAIN VIEW, C...apeutics has now evaluated the mature Phase II dat...didate PROSTVAC(TM) that had been,obtained as part...onal,Cancer Institute (NCI) in the US., The resul...
(Date:10/7/2008)...nned 15 Patient Cohort Enrolled in Stage A of Tria...on With Carboplatin and Paclitaxel -, TUSTIN, Cal...armaceuticals, Inc. (Nasdaq: PPHM ), a clinical s...al antibodies for the treatment of cancer and,hepa...t it has completed,enrollment in the first stage o...
Breaking Medicine Technology:Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4CorVel Announces Appearance at Bank of America Health Care Conference 18732 1CorVel Announces Appearance at Bank of America Health Care Conference 18732 2San Diego State University Controlled Substance Investigation 18730 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 2Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 1Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 2
... Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Gloucester...rmaceutical,company, announced today that encourag...mbination of romidepsin and erlotinib in,non-small...human,cancer patients were presented at the Americ...eeting taking place in Los Angles,CA. The study w...
...ies Confirm That Fusion Proteins Made by Combining...onstrate Increased,Anti-Tumor Activity With No Obs..., April 18, 2007,/PRNewswire-FirstCall/ -- Peregri...rmaceutical company developing targeted,monoclonal...tis C,virus infection, today reported that data pr...
Other Medicine Technology:Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 2Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 2Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 4
...ing: The Procleix System has added a significant ... utilizes innovative technologies developed by Gen...eic acid amplification technique called Transcript...V-1/HCV Assay can simultaneously detect the presen...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...assay: Uni-Gold Recombigen HIV is a single use rap...in plasma, serum and whole blood (venipuncture). U...t of care settings as an aid in diagnosis of infec...appropriate multi-test algorithms designed for the...
The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide
Medicine Products: